Brief: Kenneth Griffin Reports 5.7% Passive Stake In Vistagen Therapeutics As Of October 4 - SEC Filing
16/10/2023 21:24
Oct 16 (Reuters) - VistaGen Therapeutics Inc VTGN.O :
* KENNETH GRIFFIN REPORTS 5.7% PASSIVE STAKE IN VISTAGEN
THERAPEUTICS AS OF OCTOBER 4 - SEC FILING
Source text for Eikon: ID:
Further company coverage: VTGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors